Clinical Pharmacology Details


ENALAPRIL


View Drug Forms

Indications & Dose:

Hypertension



Adult: Initially 5 mg once daily, lower initial doses may be required when used in addition to diuretic or in renal impairment; maintenance 20 mg onc daily; maximum 40 mg per day


Heart failure 



Adult (under close medical supervision): Initially 2.5 mg once daily, increased if tolerated to 10–20 mg twice daily, dose to be increased gradually over 2–4 weeks


Prevention of symptomatic heart failure in patients with asymptomatic left ventricular dysfunction



Adult (under close medical supervision): Initially 2.5 mg once daily, increased if tolerated to 10–20 mg twice daily, dose to be increased gradually over 2–4 weeks


Children


0.1-0.5 (atleast 0.36mg) mg/kg/day as improvised suspension of crushed tablet. 

Contraindications:

Aortic stenosis, hyper-sensitivity. Pregnancy.

Side Effects:

CNS: Anxiety, dizziness, fatigue, headache, insomnia, paresthesia


CV: Angina, hypotension, palpitations, postural hypotension, syncope (especially with 1st dose)


GI: Abdominal pain, constipation, melena, nausea, vomiting


GU: Decreased libido, impotence, increased BUN/ creatinine, UTI


HEME: Agranulocytosis, neutropenia


METAB: Hyperkalemia, hyponatremia


MS: Arthralgia, arthritis, rnyalgia


RESP: Asthma, bronchitis, cough, dyspnea, sinusitis


SKIN: Angioedema, flushing, rash, sweating


 

Cautions:

Precautions:

History of anaphylaxis, renal insufficiency (<30 ml/min), hypotension (CHF, elderly, volume depletion-diuretics, dialysis; cirrhosis), aortic stenosis, hyperkalemia (potassium supplements, potassium sparing diuretics, renal disease, diabetes), neutropenia (autoimmune diseases, collagen vascular, febrile illness, immunosuppressant drug therapy), proteinuria, renal artery stenosis, surgery/ anesthesia (excessive hypotension, correctable with fluids).


Breast-feeding: Use with caution.


Old age: May be used.

Interaction:

Drugs 


Allopurinol: Predisposition to hypersensitivity reactions to ACE inhibitors


Aspirin, NSAIDs: Inhibition of the antihypertensive response to ACE inhibitors


Azathioprine: Increased myelosuppression


Insulin: Enhanced insulin sensitivity


Iron: Increased risk of anaphylaxis with administration of parenteral (IV) iron


Lithium: Increased risk of serious lithium toxicity


Loop diuretics: Initiation of ACE inhibitor therapy in the presence of intensive diuretic therapy results in a precipitous fall in blood pressure in some patients; ACE inhibitors may induce renal insufficiency in the presence of diuretic-induced sodium depletion


Potassium: Increased risk for hyperkalemia


Potassium-sparing diuretics: Increased risk for hyperkalemia


Prazosin, terazosin, doxazosin: Exaggerated first-dose hypotensive response to α-blockers


Trimethoprim: Additive risk of hyperkalemia, especially in patient predisposed to renal insufficiency


 

Warnings:

Adverse Effects:

Lactations:

Special Precautions:

Counselling:

Side Effects Or Adverse Reactions:

Patient And Carer Advice: